• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身用抗菌药物的更新:重点关注口服制剂。

Update of systemic antimicrobials: emphasis on oral agents.

作者信息

Allen D M, Ling M L

机构信息

Department of Infectious Diseases, Communicable Disease Centre, Singapore.

出版信息

Singapore Med J. 1994 Dec;35(6):626-30.

PMID:7761891
Abstract

There has been a proliferation of antimicrobial agents in the market and we can expect many more new agents to be available for use in the hospital and community later. In the outpatient setting, the number of oral antimicrobial agents are varied, providing greater flexibility in managing community acquired infections. Unfortunately, the extensive use of antimicrobial agents has contributed to the development of resistance of some bacteria to multiple antimicrobials. This paper will review the basis of activity of antimicrobial agents commonly used in the outpatient clinic. The spectrum of antibacterial activity of these agents is discussed in relation to the common organisms encountered in general practice. Guidelines for the control of the development of bacterial antimicrobial resistance are also given.

摘要

市场上的抗菌药物种类不断增加,我们预计以后会有更多新型药物可供医院和社区使用。在门诊环境中,口服抗菌药物种类多样,为治疗社区获得性感染提供了更大的灵活性。不幸的是,抗菌药物的广泛使用导致了一些细菌对多种抗菌药物产生耐药性。本文将综述门诊常用抗菌药物的作用基础。将结合全科医疗中常见的病原体讨论这些药物的抗菌谱。还给出了控制细菌对抗菌药物耐药性发展的指南。

相似文献

1
Update of systemic antimicrobials: emphasis on oral agents.全身用抗菌药物的更新:重点关注口服制剂。
Singapore Med J. 1994 Dec;35(6):626-30.
2
Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.在抗菌药物耐药时代优化社区获得性呼吸道感染的管理。
Expert Rev Anti Infect Ther. 2006 Oct;4(5):821-35. doi: 10.1586/14787210.4.5.821.
3
Rational approach to limiting emergence of antimicrobial drug resistance.限制抗菌药物耐药性出现的合理方法。
East Afr Med J. 1997 Mar;74(3):187-9.
4
Current antimicrobial resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient setting.门诊环境中耐甲氧西林金黄色葡萄球菌的当前抗菌药物耐药谱。
Diagn Microbiol Infect Dis. 2006 Jun;55(2):129-33. doi: 10.1016/j.diagmicrobio.2006.01.003. Epub 2006 Mar 20.
5
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).新型肽脱甲酰基酶抑制剂LBM415针对呼吸道和皮肤感染病原体的抗菌活性:全球监测报告(2003 - 2004年)
J Antimicrob Chemother. 2006 May;57(5):914-23. doi: 10.1093/jac/dkl093. Epub 2006 Mar 20.
6
Managing acute lower respiratory tract infections in an era of antibacterial resistance.在抗菌药物耐药时代管理急性下呼吸道感染
Am J Emerg Med. 2006 May;24(3):329-42. doi: 10.1016/j.ajem.2005.10.001.
7
Antimicrobial resistance: factors and outcomes.抗菌药物耐药性:因素与后果
Crit Care Clin. 2006 Apr;22(2):291-311, vii. doi: 10.1016/j.ccc.2006.02.006.
8
Pharmacokinetics and pharmacodynamics of antimicrobials.抗菌药物的药代动力学和药效学
Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S89-95. doi: 10.1086/518137.
9
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.针对引起社区获得性呼吸道感染和医院获得性肺炎的病原体测试替加环素的抗菌活性。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):187-93. doi: 10.1016/j.diagmicrobio.2005.05.004.
10
Community-acquired antimicrobial resistance: is it controllable?社区获得性抗菌药物耐药性:它可控吗?
Int J Clin Pract Suppl. 1998 Jun;95:23-6.